Related references
Note: Only part of the references are listed.Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor
Fouzia Amirache et al.
BLOOD (2014)
Improved retroviral episome transfer of transcription factors enables sustained cell fate modification
J. W. Schott et al.
GENE THERAPY (2014)
Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery
Sylwia Bobis-Wozowicz et al.
SCIENTIFIC REPORTS (2014)
Direct Reprogramming of Adult Somatic Cells Into Other Lineages: Past Evidence and Future Perspectives
Monica Nizzardo et al.
CELL TRANSPLANTATION (2013)
Biosafety Features of Lentiviral Vectors
Axel Schambach et al.
HUMAN GENE THERAPY (2013)
Mechanisms of Retroviral Integration and Mutagenesis
Alessia Cavazza et al.
HUMAN GENE THERAPY (2013)
Viral and Non-Viral Approaches for Transient Delivery of mRNA and Proteins
Juliane W. Schott et al.
CURRENT GENE THERAPY (2012)
RGB marking with lentiviral vectors for multicolor clonal cell tracking
Kristoffer Weber et al.
NATURE PROTOCOLS (2012)
Regulation of FOXO protein stability via ubiquitination and proteasome degradation
Haojie Huang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery
Melanie Galla et al.
NUCLEIC ACIDS RESEARCH (2011)
Gammaretroviral Vectors: Biology, Technology and Application
Tobias Maetzig et al.
VIRUSES-BASEL (2011)
A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System
Mari Iwamoto et al.
CHEMISTRY & BIOLOGY (2010)
Integrase-defective lentiviral vectors: progress and applications
M. B. Banasik et al.
GENE THERAPY (2010)
Identification, analysis, and prediction of protein ubiquitination sites
Predrag Radivojac et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Raltegravir: The First HIV Type 1 Integrase Inhibitor
Charles Hicks et al.
CLINICAL INFECTIOUS DISEASES (2009)
Integration-deficient Lentiviral Vectors: A Slow Coming of Age
Klaus Wanisch et al.
MOLECULAR THERAPY (2009)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Salima Hacein-Bey-Abina et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Broad Antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)
Kazuya Shimura et al.
JOURNAL OF VIROLOGY (2008)
Exploration of new chromophore structures leads to the identification of improved blue fluorescent proteins
Hui-wang Ai et al.
BIOCHEMISTRY (2007)
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo
Stephanie Philippe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors
A. Schambach et al.
GENE THERAPY (2006)
The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages
Hiromi Iwasaki et al.
GENES & DEVELOPMENT (2006)
A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules
Laura A. Banaszynski et al.
CELL (2006)
Transient gene expression by nonintegrating lentiviral vectors
Sarah J. Nightingale et al.
MOLECULAR THERAPY (2006)
Lentiviral vectors pseudotyped with murine ecotropic envelope: Increased biosafety and convenience in preclinical research
Axel Schambach et al.
EXPERIMENTAL HEMATOLOGY (2006)
Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression
A Schambach et al.
GENE THERAPY (2006)
Retrovirus vectors: Toward the plentivirus?
Christopher Baum et al.
MOLECULAR THERAPY (2006)
Roles of host cell factors in circularization of retroviral DNA
JM Kilzer et al.
VIROLOGY (2003)
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Human immunodeficiency virus cDNA metabolism: Notable stability of two-long terminal repeat circles
SL Butler et al.
JOURNAL OF VIROLOGY (2002)
Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication
TC Pierson et al.
JOURNAL OF VIROLOGY (2002)
Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection
L Li et al.
EMBO JOURNAL (2001)
Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
DJ Hazuda et al.
SCIENCE (2000)
Lentiviral vectors: turning a deadly foe into a therapeutic agent
D Trono
GENE THERAPY (2000)
Share Paper
